Produced by: USA Today
December 5, 2016
Anthony Sabino, Esq., professor of law, offered his expertise to USA Today in their article regarding the antitrust trial over the Aetna-Cigma merger.
"This antitrust trial will be significant first and foremost simply because it is going to trial. This rarely happens. So, whatever the outcome just the fact this is going to court is significant. “